Research Progress of α-Synuclein Aggregation Inhibitors for Potential Parkinson's Disease Treatment
I Kalsoom, Y Wang, B Li, H Wen - Mini Reviews in Medicinal …, 2023 - ingentaconnect.com
Introduction: Parkinson's disease (PD) is characterized by fibrillation of disordered proteins
known as Lewy bodies in the substantia nigra that also undergo progressive …
known as Lewy bodies in the substantia nigra that also undergo progressive …
Baicalein exhibits differential effects and mechanisms towards disruption of α-synuclein fibrils with different polymorphs
Parkinson's disease (PD) is the second most common neurodegenerative diseases with no
cure yet and its major hallmark is α-synuclein fibrillary aggregates. The crucial role of α …
cure yet and its major hallmark is α-synuclein fibrillary aggregates. The crucial role of α …
Brazilin-7-acetate, a novel potential drug of Parkinson's disease, hinders the formation of α-synuclein fibril, mitigates cytotoxicity, and decreases oxidative stress
Z Cui, FY Guo, L Li, F Lu, CH Jin, X Wang… - European Journal of …, 2024 - Elsevier
Parkinson's disease (PD) is a prevalent neurodegenerative disorder characterized by the
accumulation of α-synuclein (α-Syn) aggregates. However, there are currently no effective …
accumulation of α-synuclein (α-Syn) aggregates. However, there are currently no effective …
The impact of α-synuclein aggregates on blood-brain barrier integrity in the presence of neurovascular unit cells
The role of the blood-brain barrier (BBB) is to control trafficking of biomolecules and protect
the brain. This function can be compromised by pathological conditions. Parkinson's disease …
the brain. This function can be compromised by pathological conditions. Parkinson's disease …
[HTML][HTML] Recent advances in natural products targeting α-synuclein aggregation or clearance in Parkinson's disease
J Gupta, KV Sashidhara - European Journal of Medicinal Chemistry …, 2023 - Elsevier
Parkinson's disease is a neurodegenerative disorder characterized by the accumulation of
misfolded α-synuclein fibrils, leading to the formation of Lewy bodies. Currently, no effective …
misfolded α-synuclein fibrils, leading to the formation of Lewy bodies. Currently, no effective …
The impact of hUC MSC–derived exosome-nanoliposome hybrids on α-synuclein fibrillation and neurotoxicity
F Aliakbari, K Marzookian, S Parsafar, H Hourfar… - Science …, 2024 - science.org
Amyloid aggregation of α-synuclein (αSN) protein amplifies the pathogenesis of
neurodegenerative diseases (NDs) such as Parkinson's disease (PD). Consequently …
neurodegenerative diseases (NDs) such as Parkinson's disease (PD). Consequently …
Influence of Protonation on the Norepinephrine Inhibiting α-Synuclein 71–82 Oligomerization
G Wang, L Zhu, X Wu, Z Qian - The Journal of Physical Chemistry …, 2023 - ACS Publications
The pathogenesis of Parkinson's disease (PD) is closely linked to the massive presence of
Lewy vesicles and Lewy axons in the cytoplasm of neurons, mainly consisting of α-synuclein …
Lewy vesicles and Lewy axons in the cytoplasm of neurons, mainly consisting of α-synuclein …
The mechanistic interaction, aggregation and neurotoxicity of α-synuclein after interaction with glycyrrhizic acid: Modulation of synucleinopathies
L Zhang, N Zhang, C Pang - International Journal of Biological …, 2024 - Elsevier
This article reveals the binding mechanism between glycyrrhizic acid (GA) and α-synuclein
to may provide further information for the modulation of synucleinopathies using bioactive …
to may provide further information for the modulation of synucleinopathies using bioactive …
In silico–guided synthesis of a new, highly soluble, and anti‐melanoma flavone glucoside: Skullcapflavone II‐6′‐O‐β‐glucoside
Guided by in silico analysis tools and biotransformation technology, new derivatives of
natural compounds with heightened bioactivities can be explored and synthesized …
natural compounds with heightened bioactivities can be explored and synthesized …